1. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF et al. Bone scintigraphy: procedure guidelines for tumor imaging. Eur J Nucl Med Mol Imaging 2003;30(12):99-106.
  2. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF et al. Breast scintigraphy: procedure guidelines for tumor imaging. Eur J Nucl Med Mol Imaging 2003;30(12):107-14.
  3. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF et al. FDG-PET: procedure guidelines for tumor imaging. Eur J Nucl Med Mol Imaging 2003;30(12):115-24.
  4. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF et al. 67Ga scintigraphy: procedure guidelines for tumor imaging. Eur J Nucl Med Mol Imaging 2003;30(12):125-31.
  5. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF et al. 131J/123J-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumor imaging. Eur J Nucl Med Mol Imaging 2003;30(12):132-9.
  6. Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF et al. 111In-pentetreotide scintigraphy: procedure guidelines for tumor imaging. Eur J Nucl Med Mol Imaging 2003;30(12):140-7.
  7. Buchmann I, Kull T, Glatting G, Bunjes D, Hale G, Kotzerke J et al. A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250/183 and (99m)Tc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy. Eur J Nucl Med Mol Imaging 2003;30:667-73.
  8. Buchmann I, Wandt H, Wahl A, Reske SN. FDG PET for imaging pericardial manifestations of Hodgkin lymphoma. Clin Nucl Med 2003;28:760-1.
  9. Buchmann I, Vogg AT, Glatting G, Schultheiss S, Moller P, Leithauser F et al. [18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferation. Cancer Biother Radiopharm 2003;18:327-37.
  10. Buck AK, Halter G, Schirrmeister H, Kotzerke J, Wurziger I, Glatting G et al. Imaging proliferation in lung tumors with PET: 18F-FLT versus 18F-FDG. J Nucl Med 2003;44:1426-31.
  11. Friesen C, Lubatschofski A, Kotzerke J, Buchmann I, Reske S, Debatin J. Beta-irradiation used for systemic radioimmunotherapy induces apoptosis and activates apoptosis pathways in leukemia cells. Eur J Nucl Med 2003;30:1251-61.
  12. Glatting G, Werner C, Reske SN, Bellemann ME. ROC analysis for assessment of lesion detection performance in 3D PET: influence of reconstruction algorithms. Med Phys 2003;30:2315-9.
  13. Hetzel M, Arslandemir C, Konig HH, Buck AK, Nussle K, Glatting G et al. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management. J Bone Miner Res 2003;18:2206-14.
  14. Höher M, Wöhrle J, Wohlfrom M, Kamenz J, Nusser T, Grebe OC et al. Intracoronary beta-irradiation with a rhenium-188-filled balloon catheter: a randomized trial in patients with de novo and restenotic lesions. Circulation 2003;107:3022-7.
  15. Kotzerke J, Volkmer BG, Glatting G, van-den-Hoff J, Gschwend JE, Messer P et al. Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer. Nuklearmedizin 2003;42:25-30.
  16. Landmann M, Glatting G. Quantitative image reconstruction in PET from emission data only using cluster analysis. Z Med Phys 2003;13:269-74.
  17. Mottaghy FM. TMS: using brain plasticity to treat chronic poststroke symptoms. Neurology 2003;61:881-2.
  18. Mottaghy FM, Pascual-Leone A, Kemna LJ, Topper R, Herzog H, Muller-Gartner HW et al. Modulation of a brain-behavior relationship in verbal working memory by rTMS. Brain Res Cogn Brain Res 2003;15:241-9.
  19. Mottaghy FM, Gangitano M, Krause BJ, Pascual-Leone A. Chronometry of parietal and prefrontal activations in verbal working memory revealed by transcranial magnetic stimulation. Neuroimage 2003;18:565-75.
  20. Mottaghy FM, Gangitano M, Horkan C, Chen Y, Pascual-Leone A, Schlaug G. Repetitive TMS temporarily alters brain diffusion. Neurology 2003;60:1539-41.
  21. Reske SN. PET and restaging of malignant lymphoma including residual masses and relapse. Eur J Nucl Med Mol Imaging 2003;30 Suppl 1:S89-96.
  22. Reuter S, Buck AK, Grebe O, Nussle-Kugele K, Kern P, Manfras BJ. Salvage treatment with amphotericin B in progressive human alveolar echinococcosis. Antimicrob Agents Chemother 2003;47:3586-91.
  23. Schirrmeister H, Buck AK, Bergmann L, Reske SN, Bommer M. Positron emission tomography (PET) for staging of solitary plasmacytoma. Cancer Biother Radiopharm 2003;18:841-5.
  24. Schirrmeister H, Hetzel M, Buck AK. Staging of Non-Small-Cell Lung Cancer with Integreted PET and CT. N Engl J Med 2003;349:1188-90.
  25. Shen C, Buck A, Polat B, Schmid-Kotsas A, Matuschek C, Gross HJ et al. Triplex-forming oligodeoxynucleotides targeting survivin inhibit proliferation and induce apoptosis of human lung carcinoma cells. Cancer Gene Ther 2003;10:403-10.
  26. Shen C, Rattat D, Buck A, Mehrke G, Polat B, Ribbert H et al. Targeting bcl-2 by triplex-forming oligonucleotide--a promising carrier for gene-radiotherapy. Cancer Biother Radiopharm 2003;18:17-26.
  27. Shen C, Buck AK, Liu X, Winkler M, Reske SN. Gene silencing by adenovirus-delivered siRNA. FEBS Lett 2003;539:111-4.
  28. Wagner M, Seitz U, Buck A, Neumaier B, Schultheiss S, Bangerter M et al. 3'-[18F]fluoro-3'-deoxythymidine ([18F]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease. Cancer Res 2003;63:2681-7.
  29. Wagner M, Seitz U, Buck A, Neumaier B, Schultheiß S, Bangerter M et al. 3´-[18F]Fluoro-3´-Deoxythymidine ([18F]-FLT) as Positron Emission Tomography Tracer for Imaging Proliferation in a Murine B-Cell Lymphoma Model and in the Human Disease. Cancer Research 2003;63:2681-7.
  30. Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C et al. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study. Ann Neurol 2003;54:93-101.